Typical timeline
3–36 months
510(k) submissions typically take 3–9 months from filing (excluding pre-submission preparation); PMA pathways with clinical trials can take 1–3 years.
United States
US market authorization for medical devices via the FDA's 510(k), De Novo, or PMA pathways.
Overview
The U.S. FDA regulates medical devices through a risk-based classification system (Class I, II, III). Most Class II devices reach market via a 510(k) premarket notification demonstrating substantial equivalence to an existing predicate device; novel devices without a predicate may use the De Novo pathway; higher-risk Class III devices generally require a Premarket Approval (PMA) supported by clinical data.
Requirements
The documentation and evidence a complete submission is normally built from.
Planning ranges
Ranges illustrate general market patterns for this pathway — they are not a quote for a specific product.
Typical timeline
3–36 months
510(k) submissions typically take 3–9 months from filing (excluding pre-submission preparation); PMA pathways with clinical trials can take 1–3 years.
Estimated cost
$10k–$500k
510(k) submissions (excluding testing) often run $10k–75k in consulting and FDA fees; PMA pathways with full clinical trials can reach into the millions.
Timelines and costs above are typical ranges illustrating general market patterns, not a quote or regulatory conclusion for your specific product. Actual figures depend on device classification, target country, and applicant readiness — professional review is required before relying on this for a business decision.
Where this applies
Jurisdictions that recognise this certification. Scope and conditions still vary by product classification.
Related
FAQ
510(k) demonstrates a new device is substantially equivalent to one already legally marketed; PMA requires independent clinical evidence of safety and effectiveness and applies mainly to Class III devices.
Foreign establishments must designate a US Agent for FDA correspondence, though this differs from an EU-style Authorized Representative.
Related
The international quality management system standard specific to medical device manufacturers, referenced by most major regulators.
View →
The manufacturing quality framework underlying most device and pharmaceutical regulatory approvals worldwide.
View →
Export documentation confirming a product is legally sold in its country of origin — often required by importing countries.
View →
Reviewed packages
Buy a defined outcome
Market Entry Sprint from $2,500 · Strategy Session $500 · Pathway Brief $1,800. Professional review required before business use. No patient data on public forms.
Reviewed launch planning
FDA 510(k) / PMA pathway briefs start at $1,800. Or book a $2,500 Market Entry Sprint that includes regulatory pathway outline, evidence flags, and a review call.
Professional review is required before business use.